The proud Founder and Owner of Yorkshire Dama Cheese, based in the North of England.
The business was born out of a love for dairy produce and a frustration at not being able to find high quality tasting cheese – predominantly halloumi cheese in the UK.
Using my pharmacist background I decided to launch Yorkshire Dama Cheese and to produce the first halloumi cheese in the North of England. Getting started wasn’t easy, particularly as I have ensured that the products are all natural (preservative free and vegetarian friendly) but my passion and determination definitely helped and the business has gone from strength to strength.
Since humble beginnings in 2014 Yorkshire Dama Cheese has won two World Cheese awards, with the last one in 2015 being the top level Gold prize! The halloumi has also been shortlisted as Best Cheese in Yorkshire too.
Personally I have also been recognised for my achievements as 6th Entrepreneur of the Year in Yorkshire in 2014 and nominated as a key figurehead for International Women’s day in 2015 by the British Prime Minister.
Within the food industry my cheese making expertise and strong passion for great cooking is also drawing significant attention: I featured on British Celebrity Chef James Martin’s Home Comforts TV programme in January 2016 and have been commissioned for a new Channel 4 cooking programme also.
20+ years of experience in drug discovery and clinical development including management of phase I, II, and III studies.
Expertise in Early Development including developing strategy for 15+ IND/FIH submissions. Developed strategy for execution of over 200 clinical pharmacology studies to support Phase II/III and NDA filings
Experience with large international Phase 3 studies (up to 5400 patients) implementing novel approaches to meet development program goal of accelerated NDA submissions. Participated in sponsor and investigational site inspection readiness activities as part of scheduled and potential regulatory agency inspections
Member of Development Operations leadership team to develop strategy and goals to drive higher capabilities, productivity and quality levels. Participated in R&D Quality and Compliance routine audits to identify process gaps, develop corrective actions plans, and implement training plans
Created a highly motivated teams through effective leadership, coaching and people management ensuring an objective and performance-led management culture.
Christina’s breadth of experience and understanding of clinical research comes from working throughout healthcare and clinical research in academics, medical institutions, local government (public health), and the medical device industry. She is the Director of Clinical Affairs at ReCor Medical, a Palo-Alto based company studying an ultrasound-based renal denervation technology to treat hypertension. She thrives on being challenged, creative and innovative while building highly effective and impactful clinical teams. She enjoys mentoring and leading others positively through her actions and energy.
Areas of Interest: Leadership, Clinical Research, Trial Management, Monitoring, Health Education, Project Management, Lecturer, Epidemiology, Public Health, Certified Clinical Research Associate, Leading remote and in-house teams.
Robert sits on various Finance & Leasing Association (hyperlink) committees as well as being deputy Chairman of the Asset Finance Professionals Association (again hyperlink) which is the UK’s Asset Finance industry charity and is a Founder Fellow of The Leasing Foundation (again hyperlink). Robert has previously sat on the Board of several major UK Charities including the National Autistic Society and Arts for All and is currently a main Patron of The Royal Albert Hall.
Robert is responsible for growing and expanding LTi business throughout the UK, Nordics and Europe.
Gale McCandlish is an experienced Quality Assurance professional with an extensive background in GCP and GLP compliance for both pharmaceutical companies and CROs. In her current role as Associate Director, Vendor Compliance at Gilead Sciences, Ms. McCandlish is accountable for GCP vendor risk management and audit strategy. During the COVID-19 pandemic, Gale authored a remote audit process to ensure the continuation of vendor audit oversight responsibilities when onsite audits are not feasible.
Gale holds a BS in Biology from Bemidji State University and completed graduate work towards an MS in Biology from The George Washington University
